Barely Significant
← all excerpts

Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma.

Br J Cancer · 2013 · PMC3708560 · PMID 23787916

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

marginally significantP <0.1so close (0.05 < p ≤ 0.1)
The light grey shading on Figure 3b indicates that treatment differences in Q-TWiST were either significant ( P⩽ 0.05) or marginally significant (0.05< P <0.1) for most utility combinations, with the exception of the left-bottom corner with TOX and REL utilities both <0.2.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.